Drug intelligence / Profile preview

autologous bone marrow-derived stem cells (Stem Cell Therapy Argentina)

Development stage
Unknown
Lead developer
University of Miami
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intra-arterial
01

Overview

This investigational cell-based therapy involves the intrapancreatic infusion of autologous bone marrow-derived stem cells in combination with hyperbaric oxygen therapy (HBO) for the treatment of type 2 diabetes mellitus. Developed by Dr. Rodolfo Alejandro at the University of Miami in collaboration with Stem Cell Argentina, the protocol utilizes the patient's own harvested bone marrow stem cells, which are delivered directly into the pancreatic arterial supply. The treatment is supplemented by multiple sessions of hyperbaric oxygen therapy both before and after the infusion to enhance cell homing, survival, and islet function. Clinical trials have demonstrated potential improvements in metabolic control, including reduced HbA1c levels and decreased insulin requirements, by potentially promoting pancreatic regeneration or improving the local microenvironment.

Other names
intrapancreatic autologous stem cell infusionautologous stem cell and hyperbaric oxygen therapyHBO-ASCT

Beyond the preview

Go deeper on autologous bone marrow-derived stem cells (Stem Cell Therapy Argentina).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived stem cells (Stem Cell Therapy Argentina).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call